Majdi Mohammad, Ashengroph Morahem, Abdollahi Mohammad Reza
Department of Agricultural Biotechnology, Faculty of Agriculture, University of Kurdistan, Sanandaj, Iran.
Research Center for Medicinal Plant Breeding and Development, University of Kurdistan, Sanandaj, Iran.
Appl Microbiol Biotechnol. 2016 Feb;100(3):1041-1059. doi: 10.1007/s00253-015-7128-6. Epub 2015 Nov 14.
Sesquiterpene lactones (SLs) are one of the most diverse groups of secondary metabolites that mainly have been observed in the Asteraceae. They are composed of a C15 skeleton bearing functional groups, e.g., hydroxy, keto, or epoxy. Sesquiterpene lactones have been shown to display several biological activities; hence, their therapeutic effects are indispensable. To overcome low yield of sesquiterpene lactone content in native plants, manipulation of their biosynthetic pathway(s) has become an interesting approach for many researchers. Several genetic engineering strategies have been used in plants or microbial systems for elucidation of the biosynthetic pathway and high-level production of sesquiterpene lactones. Here, we will introduce ongoing research and perspectives about the manipulation of sesquiterpene lactone biosynthesis by various non-traditional metabolic engineering strategies, along with successful examples of high-yield production of sesquiterpene lactones mainly focused on parthenolide and artemisinin in plants and microorganisms.
倍半萜内酯(SLs)是次生代谢产物中最多样化的类别之一,主要存在于菊科植物中。它们由带有羟基、酮基或环氧基等官能团的C15骨架组成。倍半萜内酯已显示出多种生物活性,因此其治疗作用不可或缺。为了克服天然植物中倍半萜内酯含量低的问题,操纵其生物合成途径已成为许多研究人员感兴趣的方法。几种基因工程策略已用于植物或微生物系统,以阐明生物合成途径并实现倍半萜内酯的高产。在此,我们将介绍通过各种非传统代谢工程策略操纵倍半萜内酯生物合成的研究进展和前景,以及主要集中在植物和微生物中高产生产小白菊内酯和青蒿素的成功实例。